Context: The Union Ministry of Health and Family Welfare officially brought the neurological drug Pregabalin under the stricter purview of Schedule H1 of the Drugs Rules, 1945.
About Health Ministry Brings Pregabalin Under Schedule H1:
What is Schedule H1?
- Introduced in India in 2013 as an amendment to check drug abuse and slow down antimicrobial resistance, Schedule H1 is a highly restricted classification for prescription drugs.
- It sits as a legal middle ground between ordinary prescription drugs (Schedule H) and heavily restricted narcotics (Schedule X). It specifically covers third- and fourth-generation antibiotics, anti-tuberculosis medications, and high-risk, habit-forming psychotropic substances.
Act Governed Under: Deployed under the statutory framework of the Drugs and Cosmetics Rules, 1945 (enforced via the parent Drugs and Cosmetics Act, 1940).
Aim: To establish absolute accountability across the pharmaceutical supply chain, enforce meticulous prescription monitoring, stop illegal trafficking, and prevent the unauthorized OTC sale of habit-forming medications.
Key Features of the Revised Regulations:
- Strict Sales Register: Pharmacists must record doctor details, patient identity, drug name, and quantity sold for every Schedule H1 medicine.
- Three-Year Record Retention: These registers must be preserved for at least three years and remain available for drug inspector audits.
- Red Warning Label: Schedule H1 medicines must carry a red-bordered warning box and red Rx symbol on packaging.
- No Repeat Sale Without Prescription: Medicines can only be sold on a fresh prescription from a Registered Medical Practitioner (RMP).
Significance of Bringing Pregabalin Under Schedule H1:
- Controls Drug Abuse: Restricts easy access to Pregabalin, which is often misused for its sedative and euphoric effects.
- Prevents Fatal Overdoses: Reduces dangerous mixing of Pregabalin with opioids or alcohol that can cause severe respiratory depression.
